Skip to main content
Clinical Trials/NCT01403688
NCT01403688
Completed
Not Applicable

Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer

University of Kansas1 site in 1 country9 target enrollmentJune 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
University of Kansas
Enrollment
9
Locations
1
Primary Endpoint
evaluation with pre- and post-treatment(COH) breast cytomorphometry and biomarkers
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Fertility drugs have the effect of increasing hormone levels. Higher hormone levels from infertility treatments may increase breast cancer risk, but there has not been enough research to know for sure. Researchers want to use a method of taking breast tissue cells from women who are having infertility treatment. The breast tissue cells might show changes that would indicate an increased risk of cancer. The method of taking the breast tissue cells is called Fine Needle Aspiration (FNA).

The purpose of this study is to examine the changes in breast tissue, in women at high risk of breast cancer who are being treated with controlled ovarian hyperstimulation.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
August 2014
Last Updated
11 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

evaluation with pre- and post-treatment(COH) breast cytomorphometry and biomarkers

Time Frame: up to 12 months

Study Sites (1)

Loading locations...

Similar Trials